West Pharmaceutical Services, Inc. (WST)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:16PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 26.47B |
| Enterprise value | 26.18B |
| Trailing P/E | 47.95 |
| Forward P/E | 48.54 |
| PEG ratio (5-yr expected) | 6.55 |
| Price/sales (ttm) | 9.30 |
| Price/book (mrq) | 9.88 |
| Enterprise value/revenue | 8.94 |
| Enterprise value/EBITDA | 32.03 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.02 |
| 52-week change 3 | -1.55% |
| S&P500 52-week change 3 | 23.57% |
| 52-week high 3 | 415.73 |
| 52-week low 3 | 310.42 |
| 50-day moving average 3 | 376.99 |
| 200-day moving average 3 | 370.84 |
Share statistics
| Avg vol (3-month) 3 | 544.09k |
| Avg vol (10-day) 3 | 558.88k |
| Shares outstanding 5 | 72.84M |
| Implied shares outstanding 6 | 73.21M |
| Float 8 | 72.35M |
| % held by insiders 1 | 0.57% |
| % held by institutions 1 | 96.72% |
| Shares short (15 Apr 2024) 4 | 975.86k |
| Short ratio (15 Apr 2024) 4 | 2.72 |
| Short % of float (15 Apr 2024) 4 | 1.74% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.33% |
| Shares short (prior month 15 Mar 2024) 4 | 1.21M |
Dividends & splits
| Forward annual dividend rate 4 | 0.8 |
| Forward annual dividend yield 4 | 0.22% |
| Trailing annual dividend rate 3 | 0.78 |
| Trailing annual dividend yield 3 | 0.21% |
| 5-year average dividend yield 4 | 0.26 |
| Payout ratio 4 | 10.29% |
| Dividend date 3 | 07 Aug 2024 |
| Ex-dividend date 4 | 31 July 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 27 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 19.42% |
| Operating margin (ttm) | 18.06% |
Management effectiveness
| Return on assets (ttm) | 11.40% |
| Return on equity (ttm) | 20.84% |
Income statement
| Revenue (ttm) | 2.93B |
| Revenue per share (ttm) | 39.55 |
| Quarterly revenue growth (yoy) | -3.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 809.6M |
| Net income avi to common (ttm) | 568.7M |
| Diluted EPS (ttm) | 7.60 |
| Quarterly earnings growth (yoy) | -17.60% |
Balance sheet
| Total cash (mrq) | 601.8M |
| Total cash per share (mrq) | 8.26 |
| Total debt (mrq) | 306.6M |
| Total debt/equity (mrq) | 11.44% |
| Current ratio (mrq) | 2.61 |
| Book value per share (mrq) | 36.72 |
Cash flow statement
| Operating cash flow (ttm) | 756.6M |
| Levered free cash flow (ttm) | 143.34M |
© 2024 Yahoo. All rights reserved.